Novo Nordisk Egypt appoints New Vice President & General Manager

Ayman Saad Hassan began his career with Novo Nordisk in 2000 when he joined Novo Nordisk Pharma Gulf based out of Riyadh as medico-marketing manager and eventually was promoted to director. He later assumed marketing responsibility for the Near East South Asia business area based out of Istanbul, where he helped establish and develop different sales, marketing and medical units and disciplines across countries spanning from Turkey to India. These endeavors covered a fourth of the world’s population. He then moved back to the Gulf to eventually establish a fully-fledged organization in the UAE.

Ayman Hassan graduated from the Faculty of Medicine, Cairo University. In addition to his medical degree, Hassan carries a Master’s Degree in Business Administration (MBA) from the USA, a Master of Science (M.Sc.) in Global Management from the UK, a Diploma in Clinical Trials from the UK, and an Executive Management Strategy Execution Certificate from Harvard University.

About Novo Nordisk:

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity. Headquartered in Denmark, Novo Nordisk employs approximately 42,700 people in 79 countries and markets its products in more than 170 countries.